Search

Author/Creator Thorborn, Georgina

3. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Issue 10271 (23rd January 2021)

Authors:
Humby, Frances; Durez, Patrick; Buch, Maya H; Lewis, Myles J; Rizvi, Hasan; Rivellese, Felice; Nerviani, Alessandra; Giorli, Giovanni; Mahto, Arti; Montecucco, Carlomaurizio; Lauwerys, Bernard; Ng, Nora; Ho, Pauline; Bombardieri, Michele; Romão, Vasco C; Verschueren, Patrick; Kelly, Stephen; Sain...
Journal:
Lancet
Issue:
Volume 397:Issue 10271(2021)
Page Start:
305
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search